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Sllll~mal~ 
Target cell expression of major histocompatibility complex (MHC) class I molecules correlates 
with resistance to lysis by natural killer (NK) cells. Prior functional studies of the murine NK 
cell surface molecule, Ly-49, suggested its role in downregulating NK cell cytotoxicity by specifically 
interacting with target cell H-2D d molecules. In support of this hypothesis, we now demonstrate 
a physical interaction between H-2D d and Ly-49 in both qualitative and quantitative cell-cell 
binding assays employing a stable transfected Chinese hamster ovary (CHO) cell line expressing 
Ly-49 and MHC class I transfected target cells. Binding occurred only when CHO cells expressed 
Ly-49 at high levels and targets expressed H-2D d by transfection. Monodonal antibody blocking 
experiments confirmed this interaction. These studies indicate that the specifidty of natural killing 
is influenced by NK  cell receptors that engage target cell MHC  class  I molecules. 
N 
rK cells spontaneously lyse certain transformed or virally 
infected cells but do not kill normal cells (1, 2).  Al- 
though the molecular basis for NK cell specificity is poorly 
understood, target cell susceptibility to spontaneous cytotox- 
icity is inversely proportional to their level of expression of 
certain MHC class I molecules (3-5).  Two explanations (6) 
have been proposed. MHC class I molecules may "mask" or 
interfere with recognition of putative target cell ligands by 
activation receptors on NK cells.  Alternatively,  target cell 
MHC class I molecules may directly engage NK cell receptors 
leading to inhibitory events in NK ceils. Our previous func- 
tional studies (7)  of the murine Ly-49 molecule have sup- 
ported the latter hypothesis. 
Ly-49 is a type II integral membrane protein (8, 9), with 
an external C-type lectin domain (9), expressed on a distinct 
subset of murine NK cells (10) as a disulfide-linked homodimer 
of44-kD subunits (9). Functional studies with IL-2-activated 
NK  cells  demonstrated  that  Ly-49 +  NK  cells  generally 
manifested a lytic capacity equivalent to Ly-49-  NK cells 
(7).  However, Ly-49 + NK cells were unable to lyse targets 
of H-2 k or H-2 d haplotype despite efficient lysis of these 
targets by Ly-49-  NK cells,  demonstrating that Ly-49 ex- 
pression significantly influences NK  cell target  specificity. 
Transfection of a susceptible target cell line with cDNA en- 
coding H-2D a rendered it resistant to lysis by Ly-49 + NK 
cells. Ly-49 + NK cells were unable to lyse the D a transfec- 
tant by other stimuli, including Ab-dependent cellular cyto- 
toxicity (7,  11). Gene transferred resistance was abrogated 
by mAbs against either Ly-49 or the otl/o~2 domain of D a. 
These data were compatible with our hypothesis that Ly-49 
is an inhibitory receptor that specifically recognizes D a mol- 
ecules on targets. 
Our interpretation of t.hese functional studies predicts that 
Ly-49  directly  interacts  with  H-2D d.  Alternatively,  the 
results may be explained by a NK cell surface molecule that 
is coexpressed with Ly-49 and that is indirectly influenced 
by  the  anti-Ly-49  mAb.  Moreover,  reversal  of functional 
inhibition by mAbs could be due to other effects such as 
direct anti-Ly-49  triggering  or anti-H-2D d dissociation of 
another effector cell ligand (12).  A final possibility involves 
the "masking model" in which H-2D a masks another target 
molecule specifically recognized by Ly-49 (13). To distinguish 
between these possibilities, we sought to unequivocally es- 
tablish the ligand for Ly-49. We have now overexpressed Ly-49 
on Chinese hamster ovary (CHO) cells by transfection and 
DNA amplification. CHO cells bind target cells only when 
the cells express high levels  of Ly-49 and H-2D a,  respec- 
tively, by transfection. This interaction is specifically blocked 
by appropriate mAbs. Thus, this study demonstrates that Ly-49 
is a receptor for a MHC class I molecule, further substan- 
tiating a role for target cell MHC class I molecules in innate 
immunity in addition to acquired (T cell-mediated) immunity. 
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Cell Culture.  All cell lines were maintained in RPMI 1640 (Me- 
diatech Inc., Washington, D.C.) supplemented with 10% FCS (Hy- 
clone Labs., Logan, UT) 100 U/m1 penicillin K, 0.1 ms/m1 strep- 
tomycin  sulphate,  and  0.3  mg/ml  t-glutamine  (GIBCO BRL, 
Gaithersburg,  MD). CHO cells, deficient in the dihydrofolate reduc- 
tase gene (dhfr-), were grown in Ham F-12 media with the above 
supplements. The C1498  transfectants, expressing D d, K a, or L d, 
were described previously (7) and were maintained in media con- 
taining 0.5  mg/ml G418 (GIBCO BILL). 
mAbs.  The mAbs A1 (anti-Ly-49) and PK136 (anti-NKl.1) have 
been previously described (14, 15). The anti-MHC mAbs were 34- 
5-8S (anti-c~l/cx2 domains of D a, 34-2-12 (anti-oe3 domain of Da), 
and  B22.249  (anti-D b)  (16, 17). All  anti-MHC  mAbs bind  to 
C1498-D d target cells at the same density by flow cytometry (data 
not shown). 
Production and Amplification of Ly-49 + ClIO Cells.  The HindlII 
fragment  of pal.3  (9)  was  subcloned  into  the  HindlII  site  of 
pH/~APr-1 neo (18). Constructs containing the Ly-49 cDNA in 
the sense and inverse (Inv) orientation with respect to the promoter 
were identified and done& The EcoRI-PvuII fragment of pSV2- 
dhfr (19) containing the dhfr cDNA was subeloned into the Eco 
ILl site of both Ly-49 expression constructs. The resulting plasmids 
contained the Ly-49 cDNA (in either the sense or inverted orienta- 
tions) under the control of the human ~-actin promoter and the 
dhfr cDNA under the control of the SV40  early promoter. The 
plasmids were linearized by EcoRI digestion and individually elec- 
troporated (Gene Pulser; Bio-Rad Laboratories,  Hercules, CA) into 
dhfr-  CHO cells. Resistant ceils were initially selected and cloned 
in 1.5 mg/ml G418. Clones were then transferred to c~-MEM media 
(ICN/Flow, Costa Mesa, CA) with 10% dialyzed FCS. Cells trans- 
fected with the Ly-49 sense construct, that grew in both selection 
medias and expressed Ly-49 on their surface by FACS  |  analysis 
(Becton Dickinson & Co., Mountain View,  CA), were subjected 
to three rounds of amplification with successively higher concen- 
trations of methotrexate (MTX; Sigma Chemical Co., St. Louis, 
MO)  and  maintained  at  1.28  /~M  MTX  to  establish  Ly-49 High 
CHO cells. In parallel  cultures, CHO cells transfected with the 
inverse oriented construct were subjected to the same selection and 
three rounds  of MTX  amplification but  clones were randomly 
picked. The Ly-49 ~nV CHO cells were also maintained in 1.28/~M 
MTX.  Ly-49  g~  CHO cells  were isolated from cells  transfected 
with the sense construct after a single cycle of MTX amplification 
and were maintained in 20 nM MTX. 
Rosette Assay.  Ly-49His  h CHO or Ly-49~n~CHO cells (3  x  104) 
were grown overnight in 24-well tissue culture plates and washed 
twice with wash buffer (HBSS with 3% FCS). The targets were 
washed  twice  with  cold  wash  buffer  and  diluted  to  6  x  105 
cells/ml; 500k aliquots were added to each well and incubated for 
45 min in a 37~  5% CO2 incubator. Wells were washed twice 
with wash buffer and photographed with a phase contrast inverted 
microscope. 
Quantitative Binding Assay.  This assay uses centrifugation of 
inverted 96-well  plates  to  remove unbound  labded  target  cells 
from CHO cell monolayers, permitting reproducibility and objec- 
tivity (modified from 20).  In this  assay, CHO  cells  (6  x  103) 
were grown  overnight  in  a  96-welI  tissue  culture  plate.  Target 
cells were washed twice with  ILPMI 1640  (without  FCS).  The 
fluorescent dye, BCECF-AM (2',7'-bis-[2-carboxyethyl]-5-[and-6]- 
carboxyfluorescein, acetoxymethyl ester; Molecular Probes, Inc., 
Eugene, OIL), was solubilized in DMSO and diluted to 50/zg/ml 
in RPMI 1640.  The target cells (4  x  106) were resuspended in 
1 ml of diluted BCECF-AM and incubated for 2 h in a 37~  5% 
CO2 incubator.  Target cells were then washed twice with cold 
wash buffer and diluted to 1.6  x  10  ~ cells/ml. 50k aliquots were 
added to washed CHO cell monolayers and returned to the CO2 
incubator for 45 min. Wells were filled to a bulging meniscus with 
wash buffer, sealed with waterproof tape, inverted, and centrifuged 
in the upside down position at 300 g  for 4 min. While still in- 
verted, the sealant tape was removed, the plate drained, blotted, 
and reverted to the upright orientation. The remaining cells were 
lysed with  100X of lysis buffer (25 mM Tris, 0.1%  SDS).  100X 
aliquots from each well were transferred into a disposable cuvette 
filled with 4 ml of lysis buffer.  Relative fluorescence  (RF) (com- 
pared to buffer alone) was determined with a spectrofluorimeter 
(Fluorolog 2; Spex,  Inc., Edison,  NJ) at 502  nM excitation and 
530 nM emission. Percent specific binding was calculated with the 
following formula: (RF~ple  -  RFafi-c,o)/(RF~  -  RFa~-cHo). 
RFs~mplc is the RF of the experimental sample whereas ILFaf,-cao 
is the background fluorescence  remaining in wells with untrans- 
fected dhfr- CHO cells (always <8% of RFm~) and RFm~ is the 
total fluorescence  added to each well as measured by fluorescence 
of unwashed wells with labeled targets and dhfr- CHO cells. The 
mean of duplicate wells for each point was used in the calcula- 
tion.  In experiments that used mAbs, saturating concentrations 
(1:200-1:500)  of ascites preparations were added to target cells or 
to CHO cell monolayers 30 min before the assay. 
FACS |  Analysis.  A FACScan |  with the Consort 32 software 
program (Becton Dickinson & Co.) was used to analyze CHO cells 
for Ly-49 expression with mAb A1 (anti-Ly-49) as described previ- 
ously (7). 
_j- 
Log Fluorescence 
Figure  I.  Expression of Ly-49 on CHO cells. Ly-49Hig  h (histogram I), 
Ly-49  g~  (2), Ly-49  lnv (3), and parental dhfi-deficient CHO cells (4) were 
indirectly  stained with  anti-Ly-49 mAb  and  FITC-conjugated  goat 
anti-mouse Is, and analyzed by flow cytometry as described (7). Back- 
ground staining of Ly-49his  h and Ly-49  L~  cells (either unstained or with 
second-step reagent alone, data not shown) overlap histograms 3 and 4. 
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Ly-49~i~  h ClIO Cells Rosette H-21~ Targets.  To determine 
a specific physical interaction between Ly-49 and H-2D  d, our 
experimental approach employed binding assays between trans- 
fected cells expressing high levels of Ly-49 and transfected 
target cells expressing various MHC class I molecules. Similar 
systems successfully established the physical interaction be- 
tween CD4 and CD8 and their respective MHC ligands (21, 
22).  The dhfr-  CHO cells were transfected with an expres- 
sion plasmid containing the Ly-49 cDNA and dhfr.  Ly-49 
expression was amplifed by exposing positive clones to suc- 
cessively higher concentrations of MTX. Two cell lines, Ly- 
49  l-Iigh and Ly-49  r~  CHO  cells  were developed.  By flow 
cytometry, Ly-49rtig  h CHO  cells expressed Ly-49 at 30-40 
times  the level on Ly-49  r~  CHO  cells  (Fig.  1)  which in 
turn was comparable to Ly-49 + NK cells constitutively ex- 
pressing Ly-49 (data not shown). Immunoprecipitation analysis 
with mAb A1 (anti-Ly-49) showed that Ly-49 was appropri- 
ately expressed on Ly-49 + CHO  cells as a disulfide-linked 
homodimer with  the  expected molecular mass  (data  not 
shown).  In  parallel  cultures,  a  control cell  line,  Ly-49  I~v 
CHO, was produced by transfection with a plasmid containing 
an inverted Ly-49 cDNA and subjected to  the same three 
rounds of MTX amplification as Ly-49uig  h CHO cells. Pa- 
rental and Ly-49  I~v CHO cells did not express Ly-49 (Fig.  1). 
Ly-49His  h CHO  cells  were qualitatively  able  to  rosette 
transfected cells expressing H-2D  d (C1498-Da),  whereas un- 
transfected C1498  and C1498-K  a cells did not bind (Fig.  2). 
Binding of C1498-D d cells was specific for Ly-49Hig  h CHO 
cells because they did not bind Ly-49  Inv CHO cells.  Thus, 
rosette formation between these transfected cells appeared to 
be dependent on a  specific interaction between Ly-49 and 
H-2D  d. 
LF49 Specifically Recognizes H-2D  a.  To eliminate any sub- 
jective bias  in our rosette analysis,  a quantitative assay was 
developed in which the only detectable binding was between 
Ly-49 r~igh CHO  cells  and C1498-D d cells  (Fig.  3 A).  Un- 
transfected C1498,  C1498-K  a, and C1498-L d did not adhere 
to  Ly-49~ig h  CHO  cells.  The Ly-49  I"v CHO  cells  did not 
bind any targets.  A  high level of Ly-49 expression was re- 
quired for binding because C1498-D  d cells did not adhere 
to Ly-49  r~  CHO cells (Fig. 3 B). Thus, in rosette and quan- 
titative assays, adhesion between transfected CHO and C1498 
cells demonstrated an interaction between Ly-49 and H-2D  d. 
The specificity of this interaction was further confirmed 
by  mAb  blocking  studies.  Preincubation  of  Ly-49Hig  h 
CHO cells with mAb A1 (anti-Ly-49) prevented binding to 
C1498-D d cells,  whereas an isotype control mAb had no 
effect (Fig.  4).  Incubation of C1498-D a cells with a mAb 
specific  for  otl/ot2  domains  of D d also  blocked binding. 
mAbs directed against D b or the or3 domain of D d had no 
effect despite equivalent binding of all mAbs to C1498-D a 
cells by FACS  |  analysis  (data not shown). Similar analysis 
with the rosette assay confirmed these results (data not shown). 
Discussion 
In this report, we describe a physical interaction between 
Ly-49 and  H-2D  d in  binding  assays in  which  target  cells 
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Figure  2.  Ly-49Hig  b CHO  cells 
rosette  H-2Dd-expressing  target 
cells. Parental C1498  (a and d)  or 
C1498 ~  transfected with cDNAs 
encoding D d (b and e) or K d (c and 
J) were assayed for ability to rosette 
with  Ly-498i8  h  (a-c)  or  Ly-491nv 
CHO cells (d-j). The CHO ~ls ap- 
pear as large polygonal cells whereas 
target  cells are  small,  round,  and 
refractile,  x50. =0 
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Figure  3.  Quantitative binding of target cells e~pressing H-2D  d to Ly- 
49Hig  h CHO cells. (A) Ly-49Hig  h, or Ly-491" CHO cells were tested for 
ability to bind parental CI498 target cells, or C1498 cells transfected with 
cDNAs encoding H-2D  a, K a, or L  a in a quantitative fluorescence binding 
assay. (B) Binding depends on level of Ly-49 expression on CHO cells. 
Ly-49Hig  h, Ly-49  I-~  and Ly-49  Inv CHO cells were assayed for binding pa- 
rental C1498 cells or C1498-D a cells. 
adhere to CliO cells only when the target expresse(t H-2D a 
and the CHO cell expresses Ly-49 at high levels. The specificity 
of this interaction  was therefore established  in a system in 
which adherent cells differed from nonadherent cells only by 
transfection  and expression  of the relevant cDNAs,  mAb 
blocking experiments confirmed this specificity. Thus, Ly-49 
specifically  engages H-2D a molecules. 
While this manuscript  was being prepared, complemen- 
tary results were reported by Kane (23) who showed that 
Anti-NK  1.1 
Anti-D d  (x I/(x2 
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Anti-D b 
Ant1-Ly-49 
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Figure  4.  mAbs specific for Ly-49 or (xl/(x2 domains ofH-2D a block 
binding. Quantitative binding  between Ly-49H~ CHO cells and C1498-D  a 
cells was assayed in the absence or presence of the indicated mAbs. Ly- 
49  I"v CHO cells failed to bind target cells (Fig. 3 and data not shown). 
the ability of tumor cells, such as EL-4, to bind immobilized 
immunopurified H-2D d could be correlated with Ly-49 ex- 
pression.  Binding of EL-4 was also detected  to H-2K b and 
H-2D k. Previous  NK cell functional results predicted  that 
Ly-49  should bind to  H-2D a and  an  H-2LMHC  class  I 
product, consistent with H-2D k, as reported (7, 23). How- 
ever, Ly-49 belongs to a family of highly related molecules 
(24, 25) encoded by crosshybridizing transcripts of similar 
size. It thus remained possible that EL-4 cells could express 
these related molecules,  each binding different MHC class 
I molecules.  Although anti-Ly-49 mAb specifically blocked 
EL-4 binding to immunopurified H-2D d and H-2D k,  the 
mAb could recognize Ly-49-related molecules. Another pos- 
sible interpretation of the EL-4 experiments is that the mAb 
could sterically hinder binding of an unrelated molecule, coex- 
pressed and physically  associated with Ly-49,  that actually 
mediates  binding to  MHC  dass I molecules.  Our results 
eliminate  these possible alternative interpretations  because 
binding only occurred when paired cell lines express Ly-49 
and H-2D a, respectively,  by transfection. 
Our current results also differ from the EL-4 binding studies 
in  the  anti-H-2D d  mAb  blocking  experiments  and  in 
binding to H-2K  b (23). In EL-4 binding, the H-2Da-(x3  do- 
main appeared to be nearly as important as the o(1/o(2  do- 
main. In contrast,  functional studies demonstrated  that the 
same anti-H-2Da-ot3 domain mAb had no effect, suggesting 
that the (x3 domain is not involved (7). Other studies (26, 
27) have also demonstrated  that specific amino acids in the 
or1 helix can regulate MHC dass I-associated  target cell sus- 
ceptibility to NK cells.  A  single substitution in HLA-A2 
(His-74 to Asp-74) converted a nonprotective phenotype into 
one that was protective (26). A possible explanation for this 
discrepancy is that other cell surface molecules on EL-4 cells 
may contribute to its binding to immunopurified MHC class 
690  NK Cell Receptor for MHC Class I I molecules. Similarly,  EL-4 binding to H-2K  b differed from 
its  binding  to  H-2D d and  H-2D  k because the  anti-Ly-49 
mAb did not block binding of EL-4 to H-2K  b (23). Indeed, 
there  was  no  prior  evidence  suggesting  that  H-2K  b,  ex- 
pressed by several sensitive targets, had any effect on cytotox- 
icity by Ly-49 + effector cells (7). Moreover, in our current 
experiments, the various C1498 targets express H-2K  b nor- 
mally and at the same levels (7) but do not bind Ly-49  High 
CHO cells.  Thus,  binding of Ly-49 + EL-4 cells  to H-2K  b 
is not due to Ly-49 and may be due to other molecules ex- 
pressed by EL-4. 
Our  current  results  suggest  that  binding  of Ly-49  to 
H-2D  d primarily  involves the peptide binding  domains  of 
MHC class  I molecules in a manner  similar to interaction 
of MHC class I-restricted TCRs rather than CD8 molecules 
(28,  29).  The  possible  binding  of Ly-49  to  the  H-2D  a- 
otl/ot2 domain suggests that bound peptides may alter MHC 
class I-associated protection by influencing interaction with 
NK cell receptors. The ability to assay a physical interaction 
between Ly-49 and MHC class I molecules should permit 
exploration  of this  hypothesis  and  determination  of the 
significance  of the C-type lectin homology of Ly-49 (9). 
The current results clearly suggest that, in natural killing, 
MHC class I-associated target cell resistance may be attrib- 
uted to specific recognition of target cell MHC class I mole- 
cules by NK cell receptors such as Ly-49. When considered 
together  with  previous  functional  studies  with  Ly-49 § 
effector cells, the physiologic role of physical interaction be- 
tween Ly-49 and H-2D d is probably not cell adhesion per 
se even though we have used cell adhesion to demonstrate 
this interaction.  The quantitative assay demonstrated that a 
lower level of Ly-49 expression, comparable to constitutive 
expression on Ly-49 + NK cells was insufficient to produce 
detectable cell adhesion.  This suggests that the binding affinity 
may be relatively low, i.e.,  TCR-MHC interaction (30), or 
alternatively, Ly-49 could bind with high affinity to only a 
subset of H-2D  a molecules, perhaps those displaying specific 
peptides. Although further studies are necessary to delineate 
the precise mechanism by which D ~ engagement  of Ly-49 
subsequently influences NK cell cytotoxicity, we favor the 
hypothesis that physical engagement of Ly-49 subsequently 
triggers  an inhibitory signal that  overrides NK cell activa- 
tion (6, 7, 11). This interpretation also suggests that an NK 
cell possesses another receptor responsible for NK cell acti- 
vation in natural  killing.  Therefore,  the susceptibility of a 
target to a particular NK cell may be determined by target 
expression of specific MHC class I molecules and a putative 
ligand  for the activation  receptor,  as well as expression of 
the appropriate  specific  NK cell receptors. 
We thank  Dr.  David Margulies for helpful discussions and critical review of this manuscript. 
This  work was supported  by National  Institutes  of Health grants  AI-29981 and AI-33903 to W.  M. 
Yokoyama. 
Address correspondence to Dr. W. M. Yokoyama, Department  of Medicine, Box 1269, Mount Sinai Med- 
ical Center,  One Gustave L. Levy Place, New York, NY 10029. 
Received for publication 16 March I994 and in revised  form  17 May 1994. 
~eferert  ces 
1.  Heberman,  R.B. 1982. NK Cells and Other Natural Effector 
Cells. Academic Press, New York. 1566 pp. 
2.  Trinchieri, G.  1989. Biology of natural  killer cells. Adv. Ira. 
munol. 47:187. 
3.  Quillet,  A.,  F. Presse, C.  Marchiol-Foumiganlt,  A.  Hard- 
Bellan, M. Benbunan, H. Ploegh, and D. Fradelizi. 1988. In- 
creased resistance to non-MHC restricted cytotoxicity related 
to  HLA A,B  expression.  Direct  demonstration  using  /32- 
microglobulin-transfected  Daudi cells. J. Immunol. 141:17. 
4.  Piontek,  G.E., K. Taniguchi, H.G. Ljuggren,  A. Gronberg, 
R. Kiessling, G. Klein, and K. K~rre. 1985. Yac-1 MHC class 
I variants reveal an association between decreased natural killer 
sensitivity and increased H-2 expression after interferon treat- 
ment or in vivo passage. J. Imraunol. 135:4281. 
5.  Storkus W.J., J. Alexander, J.A. Payne, J.R. Dawson, and P. 
Cresswell.  1989. Reversal of natural  killing susceptibility in 
target cells expressing transfected class I HLA genes. Proc Natl. 
Acad. Sci. USA.  86:2361. 
6.  Ljunggren,  H.G.,  and K. I~rre.  1990. In search of 'missing 
self': MHC molecules and natural killer cell recognition.  Im- 
raunol. Today. 11:237. 
7.  Karlhofer, F.M., R.K. Ribaudo, and W.M. Yokoyama. 1992. 
MHC class I aUospecificity of Ly-49  § IL-2 activated natural 
killer cells. Nature (Lond.). 358:66. 
8.  Chan, P.-Y., and F. Takei. 1989. Molecular cloning and char- 
acterization of a novel T cell surface antigen,  YE1/48. J. Im- 
munol. 142:1727. 
9.  Yokoyama, W.M., L.B. Jacobs, O. Kanagawa, E.M. Shevach, 
and D.I. Cohen.  1989. A murine lymphocyte antigen belongs 
to a supergene family of type II integral membrane proteins. 
J. Iraraunol. 143:1379. 
10.  Yokoyama, W.M., P.J. Kehn, D.I. Cohen, and E.M. Shevach. 
1990. Chromosomal location of the Ly-49 (A1, YE1/48) mul- 
tigene family. Genetic association with the NKI.1 antigen, j. 
Immunol. 145:2353. 
11.  Karlhofer, F.M., R.K. Ribaudo, and W.M. Yokoyama. 1992. 
691  Daniels  et al.  Brief  Definitive Report The interaction of Ly-49 with H-2D  a globally inactivates  NK 
cell cytolytic activity. Transactions  of the Association of American 
Physicians. 105:72. 
12.  Raulet, D.H.  1992. A sense of something missing. Nature 
(Lond.). 358:21. 
13.  Kirre, K. 1992. An unexpected petition for pardon. Cu~ Biol. 
2:613. 
14.  Nagasawa, R., J. Gross, O. Kanagawa, K. Townsend, L.L. 
Lanier, J. Chiller, and J.p. Allison. 1987. Identification of a 
novel T cell surface disulfide-bonded  dimer distinct from the 
ce/~ antigen receptor. J. Immunol.  138:815. 
15.  Koo,  G.C., and J.g. Peppard. 1984. Establishment of mono- 
clonal anti-NKl.1  antibody. Hybridoma.  3:301. 
16.  Evans, G.A., D.H. Margulies, B. Shykind, J.G. Seidman, and 
K. Ozato. 1982. Exon shuffling:  mapping polymorphic deter- 
minants on hybrid mouse transplantation antigens. Nature 
(Lond.). 300:755, 
17.  Allen, H., D. Wraith, P. Pala, B. Askonas, and lL.A. Flavell. 
1984. Domain interactions of H-2 class I antigens alter cyto- 
toxic T-cell recognition sites. Nature (Lond.). 309:279. 
18.  Gunning, P., J. Leavitt, G. Muscat, S.-Y. Ng, and L. Kedes. 
1987. A human/3-actin expression  vector system  directs high- 
level accumulation of antisense transcripts. Proc Natl. Acad. 
Sci. USA.  84:4831. 
19.  Subramani, S., lL. Mulligan, and P. Berg. 1981. Expression 
of the mouse dihydrofolate reductase complementary deox- 
yribonucleic acid in Simian virus 40 vectors. Mol.  Cell. Biol. 
1:854. 
20.  Schnaar,  R.L., B.K. Brandley,  L.K. Needham, P. Swank-Hill, 
and C.C. Blackburn. 1989. Adhesion  of  eukaryotic  cells to im- 
mobilized carbohydrates. Methods Enzyraol.  179:542. 
21.  Doyle,  C., andJ.L. Strominger. D87. Interaction  between CD4 
and class II MHC molecules mediates cell adhesion. Nature 
(Lond.). 330:256. 
22.  Norment, A.M., lL.D. Salter, E Parham, V.H. Englehard, and 
D.R. Littman. 1988. Cell-cell adhesion  mediated by CD8 and 
MHC class I molecules. Nature (Lond.). 336:78. 
23.  Kane, K.P. 1994, Ly-49 mediates EL4 lymphoma adhesion to 
isolated class I major histocompatibility complex molecules. 
J. Extx Med.  179:1011. 
24.  Wong, S., J.D. Freeman, C. Kelleher,  D. Mager, and F. Takei. 
1991. Ly-49  multigene family. New members of a superfamily 
of type II membrane proteins with lectin-like domains.J. Ira- 
munol.  147:1417. 
25.  Smith, H.R.C., F.M. Karlhofer, and W.M. Yokoyama. 1994. 
The Ly-49 multigene family expressed by IL-2-activated nat- 
ural killer cells.  J. Imraunol. In press. 
26.  Storkus, W.J., R.D. Shter, J. Ahaander, F.E. Ward, lL.E. Ruiz, 
P. Cresswell, and L.lL. Dawson. 1991. Chss I-induced resis- 
tance to natural killing: identification  of  nonpermissive  residues 
in HLA-A2. Proc Natl. Acad. Sci,  USA.  88:5989. 
27.  Colonna, M., E.G. Brooks, M. Falco, G.B. Ferrara, and J.L. 
Strominger. 1993. Generation of  allospecific  natural killer cells 
by stimulation across  a polymorphism  of  HLA-C, Science (Wash. 
DC). 260:1121. 
28.  Potter, T.A., T.V. Rajah, IL.F. Dick II, and J.A. Bluestone. 
1989. Substitution  at residue 227 of H-2 class I molecules 
abrogates recognition  by CDS-dependent,  but  not  CD8- 
independent, cytotoxic T lymphocytes.  Nature (Lond.). 337:73. 
29.  Slater,  lL.D., A.M. Norment, B.P. Chen, C. Clayberger,  A.M. 
Krensky, D.lL.  Littman, and P. Parham. 1989. Polymorphism 
in the  c~3 domain of HLA-A molecules affects binding  to 
CD8. Nature (Lond.). 338:345. 
30.  Matsui, K., J.J. Boniface, P.A. tLeay, H. Schild, B. Fazekas 
de st Groth, and M.M. Davis. 1991. Low affinity interaction 
of  peptide-MHC complexes  with T cell  receptor. Science (Wash. 
DC). 254:1788. 
692  NK Cell Receptor for MHC Class I 